Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
Pre-Open Stock Movers 06/21: Kellogg Gains on Plans to Split in Three, Tech Stocks Rebound (more...)
View Older Stories
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $26 at Cowen
-
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
-
ACADIA Pharmaceuticals to Present at the Cowen and Company 40th Annual Health Care Conference on March 2, 2020
-
ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Acadia Pharma (ACAD) Prices 6.25M Share Offering at $40/Sh
-
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
-
Acadia Pharmaceuticals (ACAD) PT Raised to 'Street High' $66 at Cowen
-
ACADIA Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on March 11, 2019
-
ACADIA Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Acadia Pharma (ACAD) Prices 16.176M Share Common Offering at $17/Sh
-
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
-
ACADIA Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018
-
Acadia Pharma (ACAD): Nuplazid Beat Drives Upside, PT To $50 - Cowen
-
Acadia Pharma (ACAD): Encouraging KOL Feedback on Ph3 HARMONY DRP Trial - Cowen
-
Acadia Pharma (ACAD): Solid Nuplazid Beat - Cowen
-
ACADIA Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017
-
ACADIA Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Acadia Pharma (ACAD) Prices 6.06M Common Stock Offering at $33/Share
-
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
-
Pre-Open Stock Movers 03/30: (ACAD) (VICL) (ANTM) Higher; (CTRV) (VRNT) (LNDC) Lower (more...)
-
ACADIA Pharmaceuticals to Present at the Cowen and Company 36th Annual Health Care Conference on March 8, 2016
-
Pre-Open Stock Movers 02/01: (ALR) (STR) (TROV) Higher; (GPRO) (TSLA) (D) Lower (more...)
-
Acadia Pharma (ACAD) Prices 10.34M Shares at $29
-
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
-
Streetinsider.com's Hot Lunchtime Reads 11/6: (BABA) (SQ) (ACAD) (NVDA)
-
Acadia Pharmaceuticals (ACAD) Bullish Stance Reiterated at Cowen; All Eyes on PDP PDUFA, ADP Enrollment
-
Cowen Remains Bullish on Acadia Pharma (ACAD) Following Investor Meetings
-
Notable Analyst Rating Changes 8/25: (AAPL) (BAC) (RF) Upgraded; (BOKF) (SUNE) (GAS) Downgraded
-
Cowen Raises Price Target on Acadia Pharma (ACAD) Following 2Q15
-
Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
-
Pre-Open Stock Movers 11/21: (CYTX) (BID) (SPLK) Higher; (OTIV) (GME) (ARUN) Lower (more...)
-
Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform
-
Notable Analyst Rating Changes 05/15: (PLUG) (PTX) (TWTR) Upgraded; (BMY) (HII) (CXP) Downgraded
-
ACADIA Pharmaceuticals (ACAD) Announces $150M Common Stock Offering
-
Unusual 11 Mid-Day Movers 10/08: (VISN) (ALTI) (AMCN) Higher; (TWGP) (CVM) (ADHD) Lower
-
Acadia Pharmaceuticals, (ACAD) Prices 8M Share Offering at $12.50/Sh
-
Acadia Pharmaceuticals (ACAD) Announces Stock Offering
-
Notable Analyst Rating Changes 03/19: (AMX) (EBAY) (KBH) Upgraded; (DE) (CHK) (AFFY) Downgraded
-
Notable 52-Week Highs and Lows of the Day 01/28: (KERX) (NFLX) (WM) High; (SCHS) (JOSB) (RBY) Low
-
Notable Analyst Rating Changes 01/28: (BBY) (FB) (SPLS) Upgraded; (AAPL) (BBBY) (JOY) Downgraded
-
Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform
-
ACADIA Pharmaceuticals (ACAD) Announces $86M Equity Financing
-
Unusual 11 Mid-Day Movers 07/29: VCBI, ACAD, FE, CTXS, NEWP, ATX Higher; VPRT, NENG, QTM, ASIA, CVD Lower